Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jose M Olivares"'
Autor:
Ricardo Álvarez Martínez, Rosa María Tomé Rodríguez, María Álvarez Ariza, Carlos Spuch, Jose M. Olivares
Publikováno v:
Case Reports in Psychiatry, Vol 2020 (2020)
This is a case of a patient affected by Cushing syndrome that was admitted at the hospital due to hormonal problems. He had presented psychiatric symptoms that were mistakenly considered not directly connected to the pathology causing the clinical co
Externí odkaz:
https://doaj.org/article/4f76a976e7d644e581a91eb59bac6ef5
Autor:
Raquel Romay-Tallon, Tania Rivera-Baltanas, Josh Allen, Jose M. Olivares, Lisa E. Kalynchuk, Hector J. Caruncho
Publikováno v:
Biomarker Research, Vol 5, Iss 1, Pp 1-8 (2017)
Abstract Background The pattern of serotonin transporter clustering on the plasma membrane of lymphocytes extracted from human whole blood samples has been identified as a putative biomarker of therapeutic efficacy in major depression. Here we evalua
Externí odkaz:
https://doaj.org/article/488d9c79fec34f6e94d4c955d38d59be
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Externí odkaz:
https://doaj.org/article/7df32ef6bbd14238a444e76ccea5ca6b
Autor:
Hector J. Caruncho, Tania Rivera-Baltanas, Raquel Romay-Tallon, Lisa E. Kalynchuk, Jose M. Olivares
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
There is an utmost necessity of developing novel biomarkers of depression that result in a more efficacious use of current antidepressant drugs. The present report reviews and discusses a recent series of experiments that focused on analysis of membr
Externí odkaz:
https://doaj.org/article/1c9f0adbdf364d7ba890e24dd5f38fd9
Autor:
Raquel Romay-Tallon, Erin Kulhawy, Kyle J. Brymer, Josh Allen, Tania Rivera-Baltanas, Jose M. Olivares, Lisa E. Kalynchuk, Hector J. Caruncho
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Naïve depression patients show alterations in serotonin transporter (SERT) and serotonin 2A (5HT2A) receptor clustering in peripheral lymphocytes, and these alterations have been proposed as a biomarker of therapeutic efficacy in major depression. R
Externí odkaz:
https://doaj.org/article/2630129aa4ee40d382a7db61be144394
Publikováno v:
Frontiers in Pharmacology
Autor:
Juan Miguel Garrido Ocaña, Javier Quintero, JOSE CAÑETE, ANGELA IBAÑEZ, Miquel Tuson, Javier De Diego-Adeliño, Virginia Soria, Victor Perez, Jose Menchon, Jordi Espadaler Mazo, Diego Palao, Marta Puigmulé, Pilar A. Saiz, Enrique Baca-García, Marina Garriga, Maria Luisa Barrigon, Jose Villagran, Paz Garcia-Portilla, Julio Bobes, Roberto Sánchez-González, Fermin Mayoral-Cleries, Miquel Bernardo, Eva Aguilar, Gemma Safont, Eduard Vieta, Jose M Olivares
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Biblos-e Archivo. Repositorio Institucional de la UAM
Scopus
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
BMC Psychiatry
RUO. Repositorio Institucional de la Universidad de Oviedo
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Psychiatry, Vol 17, Iss 1, Pp 1-13 (2017)
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Biblos-e Archivo. Repositorio Institucional de la UAM
Scopus
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
BMC Psychiatry
RUO. Repositorio Institucional de la Universidad de Oviedo
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Psychiatry, Vol 17, Iss 1, Pp 1-13 (2017)
Background: A 12-week, double-blind, parallel, multi-center randomized controlled trial in 316 adult patients with major depressive disorder (MDD) was conducted to evaluate the effectiveness of pharmacogenetic (PGx) testing for drug therapy guidance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57ae26ca80555d358d82e1f90ec2d001
http://hdl.handle.net/10230/34398
http://hdl.handle.net/10230/34398
Publikováno v:
Neuropsychiatry. 1:275-289
The aim of this article is to highlight objective differences between antipsychotic (both first generation and second generation) long-acting injections (LAIs) and typical and atypical oral antipsychotics, in terms of clinical outcomes. A systematic
Publikováno v:
Psychopathology. 41:379-387
Background: Eating disturbances are frequent in bipolar disorder and are associated with poor outcome. Our objective is to assess the psychometric properties of a specific scale for the evaluation of eating disturbances in bipolar patients. Sampling
Autor:
Javier Garcia-Campayo, Antoni Serrano-Blanco, Miguel Martinez Roig, Juan J. Molina-Castillo, Juan L. Prados-Ojeda, Jose Manuel Olivares Diez, Oscar Medina-Ortiz, Miguel A. Garcia Escudero, Fermin Mayoral-Cleries, Javier Correas-Lauffer, Jose M Olivares
Publikováno v:
Applied Health Economics and Health Policy. 6:41-53
The availability of long-acting injectable risperidone may increase adherence to antipsychotic treatment and lead to improved clinical and economic outcomes for patients with schizophrenia.To investigate the cost effectiveness of treatment with long-